[The analysis of perioperative period in patients with lung cancer stage III, receiving the combined treatment].

Autor: Dobrodeev AIu, Zav'ialov AA, Tuzikov SA

Publikováno v: Khirurgiia [Khirurgiia (Mosk)] 2013 (11), pp. 20-3.

[Assay of methylated gene RARbeta2 in circulating DNA of blood from patients with lung cancer as a potential prognostic marker].

Autor: Ponomareva AA, Rykova EIu, Cherdyntseva NV, Skvortsova TE, Dobrodeev AIu, Litviakov NV, Zav'ialov AA, Tuzikov SA, Vlasov VV, Laktionov PP

Publikováno v: Voprosy onkologii [Vopr Onkol] 2011; Vol. 57 (3), pp. 302-7.

Cell-surface-bound circulating DNA as a prognostic factor in lung cancer.

Autor: Tamkovich SN; Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia., Litviakov NV, Bryzgunova OE, Dobrodeev AY, Rykova EY, Tuzikov SA, Zav'ialov AA, Vlassov VV, Cherdyntseva NV, Laktionov PP

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2008 Aug; Vol. 1137, pp. 214-7.

[Postoperative features in lung cancer patients receiving intraoperative radiotherapy and radiosensitization].

Autor: Dobrodeev AIu, Zav'ialov AA, Tuzikov SA, Miller SV, Rudyk IuV

Publikováno v: Voprosy onkologii [Vopr Onkol] 2006; Vol. 52 (4), pp. 414-6.

[Complications of intraoperative radiotherapy and adjuvant chemotherapy in patients with lung cancer].

Autor: Zyrianov BN; Research Institute of Oncology, Research Center, Russian Academy of Medical Sciences, Siberian Branch, Tomsk., Zav'ialov AA, Miller SV, Khodkevich BS, Kolomiets SA, Evtushenko VA, Cheremisina OV, Rudyk IuV, Tropin SV

Publikováno v: Voprosy onkologii [Vopr Onkol] 2003; Vol. 49 (3), pp. 370-2.